Open Flexible Dose Optimisation Trial Assessing Tolerability and Efficacy of Topiramate Monotherapy in Recently Diagnosed Patients With Epilepsy Who Are Treatment Naive or Have Failed One Anti-Epileptic Drug Treatment in Monotherapy
Latest Information Update: 22 Nov 2024
Price :
$35 *
At a glance
- Drugs Topiramate (Primary)
- Indications Partial epilepsies; Tonic-clonic epilepsy
- Focus Adverse reactions; Therapeutic Use
- Sponsors Johnson & Johnson
- 20 Nov 2012 Primary endpoints amended as reported by ClinicalTrials.gov.
- 24 Sep 2012 New trial record